Portfoliobreadcrumb nav

Eyestem - Trailblazing cell therapy company

Eyestem
Founders Image

Eyestem is a trailblazing cell therapy company. Its lead candidate, Eyecyte-RPE targeting age-related macular degeneration is undergoing clinical trials in humans and aiming for CDCSO and FDA approval. With a vision of democratizing access to cell therapy, Eyestem aims to develop a scalable platform capable of treating incurable diseases and transforming the global healthcare landscape.

Sector

Lifesciences

#
StemCellTherapy
#
Biologics

Milestones

  • Partnered in 2021
  • Series A in 2022

Founders

Dr. Jogin Desai
Dr. Jogin Desai
Dr. Rajani Battu
Dr. Rajani Battu
Dr. Rajarshi Pal
Dr. Rajarshi Pal

Investment Team

Dr. Ramesh Byrapaneni
Dr. Ramesh Byrapaneni
In the News
SEE ALL